RANOPRIL

This brand name is authorized in Nigeria. It is also authorized in Poland.

Active ingredients

The drug RANOPRIL contains one active pharmaceutical ingredient (API):

1	Lisinopril UNII E7199S1YWR - LISINOPRIL
	Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion.
	Read more about Lisinopril

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2611	Tablet	Ranopril Tablets 10mg TAB 10 mg 310packs	Ranopril Tablets 10mg LISINOPRIL 10 MG Lisinopril Dihydrate Ph. Eur. eqv. to Lisinopril anhydrous 10mg, Mannitol, Calcium Hydrogen Phosphate anhydrous, Maize Starch, Pregelatinised Maize Starch, Ferric Oxide (yellow), Magnesium Stearate, Purified Water. Apr-11 Drugs Imported Products 310packs Prescription Only Medicine (POM) 18/05/2022 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL LTD (INDIA), Village Ganguwala, Paonta Sahib, Himachal Pradesh – 173025, India , India	26/04/2023
04-2612	Tablet	Ranopril Tablets 5mg TAB 5 mg	Ranopril Tablets 5mg LISINOPRIL TABLETS USP Lisinopril 5mg, Mannitol, Calcium Hydrogen Phosphate, Maize Starch, Pregelatinised Maize Starch, Ferric Oxide (yellow), Magnesium Stearate, Purified Water. Apr-12 Drugs Imported Products 310packs POM 2 18/05/2022 RANBAXY NIGERIA LIMITED, ABIMBOLA STREET, ILASAMAJA, ISOLO LAGOS LAGOS 17932744 rosanna.iwuala@sunpharma.com SUN PHARMACEUTICAL LTD (INDIA), Village Ganguwala, Paonta Sahib, Himachal Pradesh – 173025, India , India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA03	Lisinopril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2611, 04-2612
PL	Rejestru Produktów Leczniczych	100133821, 100133838, 100189885